Filters
reset allTests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Mayo Clinic Laboratories Mayo Clinic United States | 5 | 5 |
|
Spinocerebellar Ataxia Panel (SCA1,2,3,6, and 7) Center for Genetics at Saint Francis Saint Francis Hospital United States | 5 | 5 |
|
SCA Panel (SCA1, 2, 3, 6, 7) test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 5 | 5 |
|
Ataxin 2 (ATXN2) gene CAG triplet repeat test Neurogenetics Department Cyprus Institute of Neurology and Genetics Cyprus | 1 | 1 |
|
ATXN2 - Repeat expansion analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Amyotrophic Lateral Sclerosis (ALS) / Dementia Panel Centogene AG - the Rare Disease Company Germany | 64 | 66 |
|
Ataxia / Spastic Paraplegia Comprehensive Panel Centogene AG - the Rare Disease Company Germany | 451 | 452 |
|
Centogene AG - the Rare Disease Company Germany | 13 | 13 |
|
Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD) Panel PreventionGenetics, part of Exact Sciences United States | 48 | 39 |
|
Amyotrophic Lateral Sclerosis (ALS) Panel PreventionGenetics, part of Exact Sciences United States | 36 | 32 |
|
Spinocerebellar Ataxia Type 2 via the ATXN2 CAG Repeat Expansion PreventionGenetics, part of Exact Sciences United States | 2 | 1 |
|
Spinocerebellar ataxia type 2 presymptomatic testing Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Genetics Service Unit National Institute of Biomedical Genomics India | 1 | 1 |
|
Molecular Diagnostic Laboratory Diagnostic Services, Shared Health Manitoba Canada | 1 | 1 |
|
Spinocerebellar ataxia 2 (SCA2, CAG expansion on ATXN2 gene) CGC Genetics Unilabs Portugal | 1 | 1 |
|
Spinocerebellar Ataxia (SCA) Type 2 Duzen Laboratories Duzen BBAGUAS Turkey | 1 | 1 |
|
Duzen Laboratories Duzen BBAGUAS Turkey | 4 | 5 |
|
Spinocerebellar Ataxia Type 2 Repeat Analysis GeneDx United States | 1 | 1 |
|
Spinocerebellar Ataxia Repeat Expansion Analysis GeneDx United States | 6 | 6 |
|
Comprehensive Ataxia Repeat Expansion Panel (SCA 1, 2, 3, 6, 7, 8, 10, 12, 17, 36, DRPLA & FRDA) MNG Laboratories (Medical Neurogenetics, LLC.) United States | 12 | 12 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.